Drug Trial Radar · NCT04786262
A Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
Last checked: Nov 19, 2026Latest source record: Sep 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
57
Planned (sponsor's estimate)
Start
Mar 29, 2021
Primary completion
Dec 31, 2027
Study completion Dec 31, 2031
Sponsor
- Lead sponsor
- Vertex Pharmaceuticals IncorporatedVertex Pharmaceuticals (VRTX)
- Sponsor type
- Industry
- First posted
- Mar 8, 2021
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion and VX-017 infusion in participants with type 1 diabetes (T1D) and impaired awareness of hypoglycemia (IAH) and severe hypoglycemia.
Conditions
- Diabetes Mellitus, Type 1
- Impaired Hypoglycemic Awareness
- Severe Hypoglycemia
Interventions
VX-880Biological
Infused into the hepatic portal vein.
VX-017Biological
Infused into the hepatic portal vein.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Part A: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs)Time frame: From VX-880 infusion to end of study (at least 5 years)
- Parts B and C: Proportion of Participants who are Insulin Independent with Absence of Severe Hypoglycemic Events (SHEs)Time frame: 1 year after achieving insulin independence (following VX-880 infusion)
- Part D: Safety and Tolerability as Assessed by Number of Participants With Adverse Events (AEs)Time frame: From VX-017 infusion to end of study (at least 5 years)
Locations
29 sites in 10 countries. Site status is shown where the registry gives one.
City of Hope
Duarte, California · Recruiting
University of California San Francisco
San Francisco, California · Recruiting
UHealth Diabetes Research Institute
Miami, Florida · Recruiting
Northwestern Organ Transplant Center
Chicago, Illinois · Completed
University of Chicago
Chicago, Illinois · Recruiting
Johns Hopkins University
Baltimore, Maryland · Completed
Massachusetts General Hospital
Boston, Massachusetts · Recruiting
Hospital of the University of Pennsylvania
Philadelphia, Pennsylvania · Recruiting
University of Pittsburgh Medical Center Montefiore
Pittsburgh, Pennsylvania · Recruiting
Baylor Scott and White Research Institute
Dallas, Texas · Recruiting
VCU Medical Center, Richmond
Richmond, Virginia · Recruiting
University of Wisconsin
Madison, Wisconsin · Recruiting
University of Alberta, Edmonton
Edmonton, Canada · Recruiting
McGill University Health Centre
Montreal, Canada · Recruiting
Toronto General Hospital (TGH)
Toronto, Canada · Recruiting
Vancouver General Hospital
Vancouver, Canada · Recruiting
CHU Lille
Lille, France · Recruiting
Centre de recherche en Biomédecine de Strasbourg
Strasbourg, France · Recruiting
Dresden Center for Islet Transplantation
Dresden, Germany · Recruiting
IRCCS Ospedale San Raffaele
Milan, Italy · Recruiting
Leiden University
Leiden, Netherlands · Recruiting
Oslo University Hospital
Oslo, Norway · Recruiting
King Abdullah International Medical Research Center (KAIMRC) - Riyadh - Endocrinology
Riyadh, Saudi Arabia · Recruiting
King Faisal Specialist Hospital & Research Centre - Riyadh - Endocrinology
Riyadh, Saudi Arabia · Recruiting
Hopiteaux Universitaires de Geneve
Geneva, Switzerland · Completed
Royal Infirmary of Edinburgh
Edinburgh, United Kingdom · Recruiting
Cardiovascular, Metabolic Medicine and Sciences, King's College London
London, United Kingdom · Recruiting
The Newcastle upon Tyne Hospitals NHS Foundation Trust
Newcastle upon Tyne, United Kingdom · Recruiting
Churchill Hospital
Headington, Oxford, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.